Key result
DR-STEMI trial tests noninferiority of distal transradial access vs. conventional access for needle-to-wire time.
Why the study?
Is distal transradial access noninferior to conventional transradial access regarding needle-to-wire time in patients with STEMI?
RCT (n=554)
Open-label
1:1
Yes
Is distal transradial access noninferior to conventional transradial access regarding needle-to-wire time in patients with STEMI?
Answers are grounded in this paper and cite their sources.
The DR-STEMI trial will determine if distal transradial access is noninferior to conventional transradial access regarding procedural time in patients with STEMI.
RATIONALE: Transradial access (TRA) constitutes the cornerstone for cardiac catheterization and is recommended by the multiple recent guidelines, irrespective of clinical presentation. The existing literature has evaluated distal transradial access (dTRA), as a feasible and safe approach in patients with chronic and acute coronary syndrome, excluding although patients presenting with ST- elevation myocardial infraction (STEMI). PRIMARY HYPOTHESIS: The current randomized clinical trial compares dTRA versus conventional TRA access in patients with STEMI undergoing coronary angiography and interventions regarding peri‑ and postprocedural characteristics. DESIGN: DR-STEMI is a prospective, open label, European, multicenter randomized-control trial which will include 554 patients (277 patients in each treatment arm). Patients with STEMI, will be screened on an all-comers basis for study inclusion and exclusion criteria, and those eligible will be allocated randomly (1:1), to dTRA versus TRA approach. The primary hypothesis of the study is that dTRA is noninferior to conventional TRA regarding the required time between the puncture of the radial artery and wire crossing of the infarct-related artery (i.e., needle-to-wire time). CURRENT STATUS: 2025, 309 patients have been enrolled in the study. Recruitment is expected to continue for approximately 12 months. TRIAL REGISTRATION: clinicaltrials.gov: NCT05605288.
No takes yet. Share an insight, caveat, or question.
Tsigkas et al. (2025) conducted an RCT in STEMI (n=554). Distal transradial access (dTRA) vs. Conventional transradial access (TRA) was evaluated on Required time between the puncture of the radial artery and wire crossing of the infarct-related artery (needle-to-wire time). The DR-STEMI trial is an ongoing randomized trial designed to evaluate whether distal transradial access is noninferior to conventional access for needle-to-wire time in 554 patients with STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: